Acro Biomedical (ACBM) Total Liabilities (2015 - 2025)

Acro Biomedical's Total Liabilities history runs 11 years deep, the most recent figure standing at $401062.0 for Q4 2025.

• In Q4 2025, Total Liabilities rose 22.67% year-over-year to $401062.0; the TTM figure through Dec 2025 stood at $401062.0 (up 22.67% YoY), while the FY2025 annual figure was $401062.0, up 22.67% from the prior year.
• Total Liabilities was $401062.0 for Q4 2025 at Acro Biomedical, down from $436942.0 in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $436942.0 in Q3 2025 to a low of $60158.0 in Q2 2021.
• Historically, Total Liabilities has averaged $246499.2 across 5 years, with a median of $284318.5 in 2021.
• The sharpest annual moves came in 2021 and 2023: Total Liabilities plunged 74.71% in 2021, then surged 188.18% in 2023.
• A 5-year view of Total Liabilities shows it stood at $117370.0 in 2021, then jumped by 71.35% to $201116.0 in 2022, then soared by 56.86% to $315473.0 in 2023, then advanced by 3.64% to $326946.0 in 2024, then climbed by 22.67% to $401062.0 in 2025.
• The last three Total Liabilities figures came in at $401062.0 (Q4 2025), $436942.0 (Q3 2025), and $370797.0 (Q2 2025), per Business Quant data.